325 related articles for article (PubMed ID: 24270109)
1. Indeterminate liver and renal lesions: comparison of computed tomography and magnetic resonance imaging in providing a definitive diagnosis and impact on recommendations for additional imaging.
Margolis NE; Shaver CM; Rosenkrantz AB
J Comput Assist Tomogr; 2013; 37(6):882-6. PubMed ID: 24270109
[TBL] [Abstract][Full Text] [Related]
2. [Effects of biphasic spiral CT, conventional and iron oxide enhanced MRI on therapy and therapy costs in patients with focal liver lesions].
Helmberger T; Gregor M; Holzknecht N; Rau H; Scheidler J; Reiser M
Rofo; 2000 Mar; 172(3):251-9. PubMed ID: 10778456
[TBL] [Abstract][Full Text] [Related]
3. Liver lesion detection and characterization in patients with colorectal cancer: a comparison of low radiation dose non-enhanced PET/CT, contrast-enhanced PET/CT, and liver MRI.
Cantwell CP; Setty BN; Holalkere N; Sahani DV; Fischman AJ; Blake MA
J Comput Assist Tomogr; 2008; 32(5):738-44. PubMed ID: 18830103
[TBL] [Abstract][Full Text] [Related]
4. Gadoxetate disodium-enhanced magnetic resonance imaging versus contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography for the detection of colorectal liver metastases.
Seo HJ; Kim MJ; Lee JD; Chung WS; Kim YE
Invest Radiol; 2011 Sep; 46(9):548-55. PubMed ID: 21577131
[TBL] [Abstract][Full Text] [Related]
5. Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating renal mass size?
Mucksavage P; Ramchandani P; Malkowicz SB; Guzzo TJ
Urology; 2012 Jan; 79(1):28-31. PubMed ID: 22202542
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Contrast-Enhanced Multiphase Renal Protocol CT Versus MRI for Diagnosis of Papillary Renal Cell Carcinoma.
Dilauro M; Quon M; McInnes MD; Vakili M; Chung A; Flood TA; Schieda N
AJR Am J Roentgenol; 2016 Feb; 206(2):319-25. PubMed ID: 26797358
[TBL] [Abstract][Full Text] [Related]
7. Utility of MRI in the Characterization of Indeterminate Small Renal Lesions Previously Seen on Screening CT Scans of Potential Renal Donor Patients.
Fananapazir G; Lamba R; Lewis B; Corwin MT; Naderi S; Troppmann C
AJR Am J Roentgenol; 2015 Aug; 205(2):325-30. PubMed ID: 26204282
[TBL] [Abstract][Full Text] [Related]
8. The costs and utility of imaging in evaluating dizzy patients in the emergency room.
Ahsan SF; Syamal MN; Yaremchuk K; Peterson E; Seidman M
Laryngoscope; 2013 Sep; 123(9):2250-3. PubMed ID: 23821602
[TBL] [Abstract][Full Text] [Related]
9. The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis.
Sangiovanni A; Manini MA; Iavarone M; Romeo R; Forzenigo LV; Fraquelli M; Massironi S; Della Corte C; Ronchi G; Rumi MG; Biondetti P; Colombo M
Gut; 2010 May; 59(5):638-44. PubMed ID: 19951909
[TBL] [Abstract][Full Text] [Related]
10. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
[TBL] [Abstract][Full Text] [Related]
11. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
Becker-Weidman DJ; Kalb B; Sharma P; Kitajima HD; Lurie CR; Chen Z; Spivey JR; Knechtle SJ; Hanish SI; Adsay NV; Farris AB; Martin DR
Radiology; 2011 Dec; 261(3):824-33. PubMed ID: 21969663
[TBL] [Abstract][Full Text] [Related]
13. Detection of liver metastases from endocrine tumors: a prospective comparison of somatostatin receptor scintigraphy, computed tomography, and magnetic resonance imaging.
Dromain C; de Baere T; Lumbroso J; Caillet H; Laplanche A; Boige V; Ducreux M; Duvillard P; Elias D; Schlumberger M; Sigal R; Baudin E
J Clin Oncol; 2005 Jan; 23(1):70-8. PubMed ID: 15625361
[TBL] [Abstract][Full Text] [Related]
14. Costs in follow-up of endovascularly repaired abdominal aortic aneurysms. Magnetic resonance imaging with MR angiography versus EUROSTAR protocols.
Engellau L; Albrechtsson U; Höjgård S; Norgren L; Larsson EM
Int Angiol; 2003 Mar; 22(1):36-42. PubMed ID: 12771854
[TBL] [Abstract][Full Text] [Related]
15. Suspicious breast lesions detected at 3.0 T magnetic resonance imaging: clinical and histological outcomes.
Johnson KS; Baker JA; Lee SS; Soo MS
Acad Radiol; 2012 Jun; 19(6):667-74. PubMed ID: 22459645
[TBL] [Abstract][Full Text] [Related]
16. The clinical impact of magnetic resonance imaging in diagnosing focal hepatic lesions and suspected cancer.
Shah AJ; Parsons B; Pope I; Callaway M; Finch-Jones MD; Thomas MG
Clin Imaging; 2009; 33(3):209-12. PubMed ID: 19411027
[TBL] [Abstract][Full Text] [Related]
17. Metastatic liver tumor from cystic ovarian carcinomas: CT and MRI appearance.
Tang Y; Yamashita Y; Ogata I; Namimoto T; Abe Y; Urata J; Takahashi M
Radiat Med; 1999; 17(4):265-70. PubMed ID: 10510898
[TBL] [Abstract][Full Text] [Related]
18. Characterization of hepatic lesions (≤ 30 mm) with liver-specific contrast agents: a comparison between ultrasound and magnetic resonance imaging.
Takahashi M; Maruyama H; Shimada T; Kamezaki H; Sekimoto T; Kanai F; Yokosuka O
Eur J Radiol; 2013 Jan; 82(1):75-84. PubMed ID: 23116806
[TBL] [Abstract][Full Text] [Related]
19. Is there a need for MRI within 24 hours after CT-guided percutaneous thermoablation of the liver?
Ringe KI; Wacker F; Raatschen HJ
Acta Radiol; 2015 Jan; 56(1):10-7. PubMed ID: 24445091
[TBL] [Abstract][Full Text] [Related]
20. Size discrepancy between sonographic and computed tomographic/magnetic resonance imaging measurement of hepatocellular carcinoma: the necessity of tumor size measurement standardization.
Cha MJ; Lee MW; Cha DI; Kim JH; Rhim H; Cho YK; Kim YJ; Choi D; Kim YS; Lim HK
J Ultrasound Med; 2013 Oct; 32(10):1703-9. PubMed ID: 24065250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
